Cargando…
Classic tumor markers in gastric cancer. Current standards and limitations
The progress made in the last few years made available a large amount of information that needs to be integrated and ordered by oncologists. Tumor markers are one of the pieces that physicians need to fit into the bigger puzzle. This article will detail the most frequent etiologies for the surges in...
Autores principales: | CĂINAP, CĂLIN, NAGY, VIORICA, GHERMAN, ALEXANDRA, CETEAN, SANZIANA, LASZLO, ISTVAN, CONSTANTIN, ANNE-MARIE, CĂINAP, SIMONA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576775/ https://www.ncbi.nlm.nih.gov/pubmed/26528057 http://dx.doi.org/10.15386/cjmed-409 |
Ejemplares similares
-
Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab
por: GHERMAN, ALEXANDRA, et al.
Publicado: (2017) -
The importance of the granulocyte-colony stimulating factor in oncology
por: CETEAN, SÎNZIANA, et al.
Publicado: (2015) -
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
por: Căinap, Călin, et al.
Publicado: (2021) -
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer
por: Gherman, Alexandra, et al.
Publicado: (2023) -
Next Generation Sequencing Technology in Lung Cancer Diagnosis
por: Cainap, Calin, et al.
Publicado: (2021)